Vastra Gotaland Region
Quick facts
Marketed products
- Bisoprolol Oral Tablet
- Dapagliflozin Oral Product
- Dipyridamole 200 mg
- Dry plasma · Hematology / Hemostasis
Dry plasma is a lyophilized (freeze-dried) blood plasma product that restores coagulation factors and other plasma proteins when reconstituted. - Progesterone vaginal tablet
- Ramipril Oral Product
Phase 3 pipeline
- busulfan, cyclophosphamide and melphalan, BuCyMel
- clofarabine, fludarabine and busulfan, CloFluBu · Oncology
CloFluBu is a combination chemotherapy regimen that inhibits DNA synthesis and repair through three nucleoside analogs, used as a myeloablative conditioning regimen prior to hematopoietic stem cell transplantation. - IPI1/NIVO3 · Oncology
IPI1/NIVO3 is a combination of an inducible T-cell co-stimulator (ICOS) agonist and a PD-1 inhibitor that enhances anti-tumor immune responses by activating T cells while removing inhibitory checkpoint signals. - IPI3/NIVO1 · Oncology
IPI3/NIVO1 is a combination of an inducible T-cell co-stimulator (ICOS) agonist and a PD-1 inhibitor that enhances anti-tumor immune responses by activating T cells while removing inhibitory checkpoint signals. - Randomisation course 2 ADxE versus FLADx · Immunology
ADxE and FLADx are both involved in the regulation of the immune system.
Phase 2 pipeline
- Anti-VEGF treatment · Oncology
Anti-VEGF treatment works by inhibiting the vascular endothelial growth factor (VEGF) pathway, which is involved in angiogenesis and tumor growth. - Capecitabine, Cyclophosphamide · Oncology
Capecitabine is a prodrug that is converted into 5-fluorouracil, which interferes with DNA synthesis, thereby inhibiting cancer cell growth. Cyclophosphamide is an alkylating agent that attaches an alkyl group to the DNA of cancer cells, thereby interfering with their replication. - Superparamagnetic Iron Oxide
Phase 1 pipeline
- Autologous Tumor Infiltrating Lymphocytes
- Cohort 1, Ceplene® and Proleukin®
- Crystalloid based prime solution
- Erythrocyte based prime solution
- Infudopa i.v.
- Infudopa s.c.
- MagTrace only
- OD dual-release Hydrocortisone
- TID Hydrocortisone
- TNF-α inhibitor OR JAK inhibitor
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Vastra Gotaland Region
What are Vastra Gotaland Region's marketed drugs?
Top marketed products include Bisoprolol Oral Tablet, Dapagliflozin Oral Product, Dipyridamole 200 mg, Dry plasma, Progesterone vaginal tablet, Ramipril Oral Product.
What is Vastra Gotaland Region's pipeline?
Vastra Gotaland Region has 5 drugs in Phase 3, 3 in Phase 2, 10 in Phase 1. Late-stage candidates include busulfan, cyclophosphamide and melphalan, BuCyMel, clofarabine, fludarabine and busulfan, CloFluBu, IPI1/NIVO3, IPI3/NIVO1.
Related
- Bisoprolol Oral Tablet
- Dapagliflozin Oral Product
- Dipyridamole 200 mg
- Dry plasma · Hematology / Hemostasis
- Progesterone vaginal tablet
- Sector hub: All tracked pharma companies